William Draper III, who brought Harvard Business School savvy to the earliest stirrings of Silicon Valley as a co-founder ...
GSK plc (NYSE:GSK) plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at ...
GSK is consolidating its vaccine manufacturing operations to one site—located in Canada—amid what a spokesperson said is ...
Sept 15 (Reuters) - GSK said on Tuesday it had agreed a deal worth up to $750 million to buy a trispecific T cell-engager (TCE), a drug designed to help T-cells target cancer, from China-based ...
Pharmaceutical major GSK plans to shut its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting around 641 jobs at risk and triggering opposition from the plant’s works council ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results